The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation.
Smith
T A
TA
MRC Cyclotron Unit, ICSM, Hammersmith Hospital, Du Cane Road, W12 ONN, London, United Kingdom. tim.smith@ic.ac.uk
D000818:Animals; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006593:Hexokinase / Q000502:physiology; D006801:Humans; D051379:Mice; D009004:Monosaccharide Transport Proteins / Q000378:metabolism; D009369:Neoplasms / Q000000981:diagnostic imaging / Q000378:metabolism*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*; D051381:Rats; D014055:Tomography, Emission-Computed; D014407:Tumor Cells, Cultured
D009004:Monosaccharide Transport Proteins; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D006593:Hexokinase